Showing results (761-770 of 3,200) with videos related to
Sort By:
Pageof 320
International Journal of Antimicrobial Agents|January 21, 2004
Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centresPaul R Rhomberg, Ronald N Jones, Helio S Sader, et al.Diagnostic Microbiology and Infectious Disease|May 14, 2003
Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001): report from the SENTRY Antimicrobial Surveillance ProgramRonald N Jones, Douglas J Biedenbach, Mondell L BeachDiagnostic Microbiology and Infectious Disease|April 6, 2004
A pragmatic approach to identify extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Taiwan: in vitro activity of newer and established antimicrobial agentsWen-Liang Yu, Yin-Ching Chuang, Ronald N JonesDiagnostic Microbiology and Infectious Disease|January 1, 1992
Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overviewD J Hardy, D R Guay, R N JonesDiagnostic Microbiology and Infectious Disease|September 24, 2004
Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002)Douglas J Biedenbach, Gary J Moet, Ronald N JonesJournal of Clinical Microbiology|October 9, 2004
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazoleM A Pfaller, A Espinel-Ingroff, R N JonesDiagnostic Microbiology and Infectious Disease|December 1, 1994
Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing EnterobacteriaceaeH S Sader, M A Pfaller, R N JonesDiagnostic Microbiology and Infectious Disease|May 1, 1994
Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study GroupM J Bale, R N Jones, M E ErwinAmerican Journal of Clinical Pathology|October 1, 1983
Contemporary quality control practices for antimicrobial susceptibility tests: a report from the microbiology portion of the College of American Pathologists (CAP) surveys programR N Jones, D C Edson, B F GilmoreJournal of Clinical Microbiology|October 1, 1993
Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganiiD J Biedenbach, R N Jones, M E ErwinPageof 320